Gknowmix

Gknowmix is positioned within the growing discipline of ‘3P Medicine’, i.e. Preventative, Personalised, and Predictive medicine.  The company’s focus is on the commercialisation of genetic R&D and associated Intellectual Property (specifically genetic screening) via the integration of genetic screening test results with clinical indicators, pathology and lifestyle factors.  Its offering to the healthcare industry is new genetic screening tests, plus accompanying interpretive reports for diagnostic and risk reduction purposes through provision of personalised treatment plans. Current Gknowmix’ products include genetic tests and accompanying interpretative reports for cardiovascular disease.

Contact:            Dr. Maritha Kotze
Telephone:       +27 (0)82 8799108